A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) Interval

Summary

This is a Phase 1, single centre, randomised, double blind (except for moxifloxacin), placebo and positive controlled, 4 way crossover study assessing the ECG effects of therapeutic and supratherapeutic doses of icosabutate in healthy male and female subjects.

Timeline

Start

2018-06-15

Primary completion

2018-09-15

Completion

2018-09-24

Drugs

Indications